BeiGene Ltd (BEIGF)
14.40
0.00 (0.00%)
USD |
OTCM |
Dec 17, 16:00
BeiGene Total Assets (Quarterly): 5.831B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Theravance Biopharma Inc | 356.10M |
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 13.59M |
| IGC Pharma Inc | 10.37M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.395B |
| Shareholders Equity (Quarterly) | 3.436B |
| Debt to Equity Ratio | 0.306 |
| Current Ratio | 1.931 |
| Net Debt Paydown Yield | -0.40% |